Sale!

CHRND Gene Myasthenic Syndrome Congenital Type 3A Slow Channel Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CHRND Gene Myasthenic Syndrome Congenital Type 3A Slow Channel Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE. Priced at 4400 AED, this test specifically targets the CHRND gene to identify mutations associated with Congenital Myasthenic Syndrome Type 3A (CMS Type 3A), a rare hereditary neuromuscular disorder characterized by muscle weakness and fatigue. The condition is attributed to a slow-channel congenital myasthenic syndrome, which results from the prolonged opening of the acetylcholine receptor channels at the neuromuscular junction, leading to a disruption in muscle contraction and strength.

This genetic test is critical for accurate diagnosis and management of the condition, providing essential information for personalized treatment plans. It involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for specific mutations in the CHRND gene. The results can have significant implications for treatment strategies, including the use of cholinesterase inhibitors or other targeted therapies that can improve muscle function and quality of life for affected individuals.

By offering this test, DNA Labs UAE plays a vital role in the early detection and management of Congenital Myasthenic Syndrome Type 3A, enabling patients and their families to understand their condition better and to explore the most effective treatment options available.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CHRND Gene Myasthenic Syndrome Congenital Type 3A Slow Channel Genetic Test

Test Details:

The CHRND gene is associated with a type of congenital myasthenic syndrome called slow channel syndrome. This syndrome is characterized by muscle weakness and fatigue, which can be present from birth or develop in childhood.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously. In the context of slow channel syndrome, NGS genetic testing can be used to identify mutations or variations in the CHRND gene that may be responsible for the condition.

The test involves obtaining a DNA sample, usually through a blood sample or cheek swab, and then sequencing the DNA to identify any abnormalities in the CHRND gene. This can help in confirming a diagnosis of slow channel syndrome and determining the specific genetic variant causing the condition.

Genetic testing can be beneficial for individuals with suspected slow channel syndrome as it can provide a definitive diagnosis, guide treatment decisions, and help with genetic counseling and family planning. It is important to consult with a healthcare professional or genetic counselor to understand the implications and limitations of genetic testing.

Test Name: CHRND Gene Myasthenic Syndrome Congenital Type 3A Slow Channel Genetic Test

Components:

  • Price: 4400.0 AED

Sample Condition:

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery:

3 to 4 Weeks

Method:

NGS Technology

Test Type:

Neurological Disorders

Doctor:

Neurologist

Test Department:

Genetics

Pre Test Information:

Clinical History of Patient who is going for CHRND Gene Myasthenic syndrome, congenital, type 3A, slow channel NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with CHRND Gene Myasthenic syndrome, congenital, type 3A, slow channel

Test Name CHRND Gene Myasthenic syndrome congenital type 3A slow channel Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CHRND Gene Myasthenic syndrome, congenital, type 3A, slow channel NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CHRND Gene Myasthenic syndrome, congenital, type 3A, slow channel
Test Details

The CHRND gene is associated with a type of congenital myasthenic syndrome called slow channel syndrome. This syndrome is characterized by muscle weakness and fatigue, which can be present from birth or develop in childhood.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously. In the context of slow channel syndrome, NGS genetic testing can be used to identify mutations or variations in the CHRND gene that may be responsible for the condition.

The test involves obtaining a DNA sample, usually through a blood sample or cheek swab, and then sequencing the DNA to identify any abnormalities in the CHRND gene. This can help in confirming a diagnosis of slow channel syndrome and determining the specific genetic variant causing the condition.

Genetic testing can be beneficial for individuals with suspected slow channel syndrome as it can provide a definitive diagnosis, guide treatment decisions, and help with genetic counseling and family planning. It is important to consult with a healthcare professional or genetic counselor to understand the implications and limitations of genetic testing.